Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001085146-14-000374
Filing Date
2014-02-11
Accepted
2014-02-10 18:29:20
Documents
1

Document Format Files

Seq Description Document Type Size
1 rgena1_21014.htm SC 13G/A 29061
  Complete submission text file 0001085146-14-000374.txt   30592
Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Subject) CIK: 0000730272 (see all company filings)

EIN.: 042729386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-38071 | Film No.: 14590716
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 101 W BIG BEAVER RD SUITE 745 TROY MI 48084
Business Address 101 W BIG BEAVER RD SUITE 745 TROY MI 48084 248-457-1200
NORTHPOINTE CAPITAL LLC (Filed by) CIK: 0001132668 (see all company filings)

EIN.: 233025935 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A